118 related articles for article (PubMed ID: 2461267)
1. The effect of antithyroid drugs on B and T cell activity in vitro.
Wilson R; McKillop JH; Chopra M; Thomson JA
Clin Endocrinol (Oxf); 1988 Apr; 28(4):389-97. PubMed ID: 2461267
[TBL] [Abstract][Full Text] [Related]
2. The effects of antithyroid drugs on intercellular mediators.
Wilson R; McKillop JH; Travers M; Smith J; Smith E; Thomson JA
Acta Endocrinol (Copenh); 1990 May; 122(5):605-9. PubMed ID: 2112814
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of immunoglobulin-secreting cells by antithyroid drugs.
Weiss I; Davies TF
J Clin Endocrinol Metab; 1981 Dec; 53(6):1223-8. PubMed ID: 6170652
[TBL] [Abstract][Full Text] [Related]
4. Graves' disease and Hashimoto's thyroiditis: effects of high doses of antithyroid drugs on thyroid autoantibody levels.
Romaldini JH; Werner MC; Rodrigues HF; Teixeira VL; Werner RS; Farah CS; Bromberg N
J Endocrinol Invest; 1986 Jun; 9(3):233-8. PubMed ID: 2428860
[TBL] [Abstract][Full Text] [Related]
5. Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves' retroocular fibroblasts.
Heufelder AE; Wenzel BE; Bahn RS
J Clin Endocrinol Metab; 1992 Apr; 74(4):737-42. PubMed ID: 1532179
[TBL] [Abstract][Full Text] [Related]
6. Local anaesthesia and immunomodulatory effects of antithyroid drugs.
Hallengren B; Melander A; Thesleff S
Acta Endocrinol (Copenh); 1984 Jul; 106(3):336-7. PubMed ID: 6741398
[TBL] [Abstract][Full Text] [Related]
7. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antithyroid drugs efficacy on P wave changes in patients with Graves' disease.
Berker D; Işik S; Canbay A; Aydin Y; Tütüncü Y; Delibaşi T; Güler S
Anadolu Kardiyol Derg; 2009 Aug; 9(4):298-303. PubMed ID: 19666432
[TBL] [Abstract][Full Text] [Related]
9. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
10. Thyroid Ca2+/NADPH-dependent H2O2 generation is partially inhibited by propylthiouracil and methimazole.
Ferreira AC; de Carvalho Cardoso L; Rosenthal D; de Carvalho DP
Eur J Biochem; 2003 Jun; 270(11):2363-8. PubMed ID: 12755690
[TBL] [Abstract][Full Text] [Related]
11. Effects of antithyroid drugs on Con A-induced suppressor cell activity.
Okabe N; Mori R; Miake S; Inoue K
J Clin Lab Immunol; 1984 Apr; 13(4):167-9. PubMed ID: 6234399
[TBL] [Abstract][Full Text] [Related]
12. Anti-thyroid drugs and lymphocyte function. I. The in vitro effect on blastogenesis and suppressor cell activity.
Goldrath N; Eisenstein Z; Bank H; Shoham J
Clin Exp Immunol; 1982 Oct; 50(1):55-61. PubMed ID: 6217000
[TBL] [Abstract][Full Text] [Related]
13. Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon-gamma-induced HLA-DR expression.
Aguayo J; Iitaka M; Row VV; Volpé R
J Clin Endocrinol Metab; 1988 May; 66(5):903-8. PubMed ID: 3129449
[TBL] [Abstract][Full Text] [Related]
14. Methimazole treatment in Graves' disease: behaviour of CD5+B lymphocytes and regulatory T cell subsets.
Paggi A; Amoroso A; Ferri GM; Mariotti A; Pellegrino C; Afeltra A
Eur Rev Med Pharmacol Sci; 1998; 2(1):11-9. PubMed ID: 9825565
[TBL] [Abstract][Full Text] [Related]
15. Antithyroid drugs inhibit thyroid hormone receptor-mediated transcription.
Moriyama K; Tagami T; Usui T; Naruse M; Nambu T; Hataya Y; Kanamoto N; Li YS; Yasoda A; Arai H; Nakao K
J Clin Endocrinol Metab; 2007 Mar; 92(3):1066-72. PubMed ID: 17192293
[TBL] [Abstract][Full Text] [Related]
16. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs.
Wenzel KW; Lente JR
J Clin Endocrinol Metab; 1984 Jan; 58(1):62-9. PubMed ID: 6196375
[TBL] [Abstract][Full Text] [Related]
17. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.
Abuid J; Larsen PR
J Clin Invest; 1974 Jul; 54(1):201-8. PubMed ID: 4134836
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
Huang CN; Hsu TC; Chou HH; Tsay GJ
J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
[TBL] [Abstract][Full Text] [Related]
19. Neonatal exposure to propylthiouracil induces a shift in lymphoid cell sub-populations in the developing postnatal male rat spleen and thymus.
Rooney AA; Fournier M; Bernier J; Cyr DG
Cell Immunol; 2003 Jun; 223(2):91-102. PubMed ID: 14527507
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.
Shiroozu A; Taurog A; Engler H; Dorris ML
Endocrinology; 1983 Jul; 113(1):362-70. PubMed ID: 6861708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
